Both in Pharmaceuticals
Elanco Animal Health Incorporated vs Summit Therapeutics
Over the past year ELAN returned +4.1% and SMMT returned −15.2%; their daily moves had a correlation of 0.18.
ELAN +4.1% SMMT −15.2%Growth of $1, one year, split-adjusted
| Metric | ELAN | SMMT |
|---|---|---|
| Price | $23.06 | $16.03 |
| Market cap | $11.52B | $12.79B |
| Today | −0.77% | −1.05% |
| 1 month | +5.9% | −4.0% |
| 6 months | +2.4% | −0.5% |
| Year to date | +1.9% | −8.3% |
| 1 year | +2.1% | −14.1% |
| Revenue growth (YoY) | +10.2% | — |
| Gross margin | 58.3% | — |
| Net margin | 3.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.3× | — |
| Net cash | -$3.39B | $690.7M |
| Dividend yield | — | — |
| Volatility (60d) | 34.2% | 68.8% |
| Short % of float | 6.3% | 29.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).